BCAR4 expression as a predictive biomarker for endocrine therapy resistance in breast cancer

Authors

Muheng Liao, Washington University School of Medicine in St. Louis
Jace Webster, Washington University School of Medicine in St. Louis
Emily M Coonrod, Washington University School of Medicine in St. Louis
Katherine N Weilbaecher, Washington University School of Medicine in St. Louis
Christopher A Maher, Washington University School of Medicine in St. Louis
Nicole M White, Washington University School of Medicine in St. Louis

Journal

Clinical Breast Cancer

Publication Date

6-1-2024

Volume

24

Issue

4

First Page

368

Last Page

375.e2

Document Type

Open Access Publication

DOI

10.1016/j.clbc.2024.02.007

Rights and Permissions

Liao M, Webster J, Coonrod EM, Weilbaecher KN, Maher CA, White NM. BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer. Clin Breast Cancer. 2024 Jun;24(4):368-375.e2. doi: 10.1016/j.clbc.2024.02.007 © 2025 The Authors. Published by Elsevier Inc.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Recommended Citation

Liao, Muheng; Webster, Jace; Coonrod, Emily M; Weilbaecher, Katherine N; Maher, Christopher A; and White, Nicole M, "BCAR4 expression as a predictive biomarker for endocrine therapy resistance in breast cancer." Clinical Breast Cancer. 24, 4. 368 - 375.e2. (2024).
https://digitalcommons.wustl.edu/oa_4/5058

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.